Influenza News and Research

Latest Influenza News and Research

New lab-on-a-chip platform for detecting SARS-CoV-2 in resource-limited settings

A recent study shows how a novel and integrated lab-on-a-chip platform can represent a rapid, affordable, and exact molecular diagnostic tool for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The paper is currently available for free on the medRxiv* preprint server while it undergoes peer review.

9 Jan 2022

Influenza vaccination does not affect risk of SARS-CoV-2 infection or COVID-19

A new study published in The Journal of Infectious Diseases examined if influenza vaccination altered the risk of SARS-CoV-2 infection and clinical outcomes of COVID-19. The study included health care workers (HCWs) from Denmark who were offered influenza vaccination.

9 Jan 2022

Comparison of COVID-19 and influenza-associated complications

Researchers compare the number, types, and risk for complications among COVID-19 and influenza patients using claims data.

9 Jan 2022

Reinfection with SARS-CoV-2 in children

These findings bear out earlier reports that COVID-19 is less frequent and severe in children than adults.

7 Jan 2022

SARS-CoV-2 Omicron belongs to new antigenic cluster compared to all other VOCs

Researchers investigate SARS-CoV-2 antigenic drift by evaluating the neutralizing activity of sera from patients infected with all five SARS-CoV-2 VOCs.

6 Jan 2022

COVID-19 vaccines effective at varying intensities of SARS-CoV-2 exposure

Researchers investigate the effectiveness of COVID-19 vaccines in individuals at high risk due to their proximity with infected individuals.

6 Jan 2022

New method to estimate how individual mutations affect transmission of SARS-CoV-2

A new study, posted to the medRxiv* preprint server, constructs an analytical SIR-based epidemiological model to analyze the effects of mutations on SARS-CoV-2 transmission from genomic surveillance data.

5 Jan 2022

Distrust in state power closely linked vaccine hesitancy

Distrust of the state in Turkey, religion and abortion resistance in the United States. Politics and culture are just as important in explaining vaccine hesitancy as health.

5 Jan 2022

Impact of delaying the lifting of SARS-CoV-2 lockdown restrictions

New study findings provided critical insights into competitive behavior and the relative transmissibility of SARS-CoV-2 variants, which could be used for planning responses to future emerging variants and exploring co-infections with different strains of SARS-CoV-2 and influenza virus.

5 Jan 2022

Can the COVID-19 delta variant evade vaccine-induced immunity?

Can the COVID-19 delta variant evade vaccine-induced immunity? We spoke to Professor Brian J. Willett from the University of Glasgow to find out.

5 Jan 2022

Novel insight into the immune characteristics of bats

Many studies have indicated that bats are significant reservoirs of innumerable viruses, such as influenza, coronaviruses, and rabies. These studies have also reported that bats predominantly remain asymptomatic or develop mild diseases during viral infections caused by henipaviruses, Ebola virus, coronaviruses, etc.

4 Jan 2022

Experts cautiously optimistic about risks of Delta-Omicron mutations mix

Researchers evaluate the risk of the P681R, N501Y, and D614G mutations of current interest co-occurring naturally due to convergent evolution.

4 Jan 2022

In vitro effect of several antiviral drugs against various SARS-CoV-2 variants of concern

An independent study confirms that current and prospective antiviral treatments are effective in inhibiting severe infection from SARS-CoV-2.

4 Jan 2022

The impact of natural selection on sequence diversity in SARS-CoV-2

Recent genomic analysis demonstrates that the SARS-CoV-2 genome is under two distinct selective forces.

3 Jan 2022

Omicron spike-specific binding antibodies attenuate disease, despite increasing transmission

Researchers investigate the capacity of vaccine-induced antibodies to generate Fc-effector activity against the SARS-CoV-2 Omicron variant.

3 Jan 2022

Echinacea, a potent antiviral against SARS-CoV-2

Researchers present available evidence on the activity of Echinacea purpure against coronavirus infections.

3 Jan 2022

The use of monoclonal antibodies against infectious pathogens

Joshua Tan of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health wrote a review article in the journal DNA and Cell Biology about the role of monoclonal antibodies and briefly described a study on bispecific antibodies that neutralize SARS-CoV-2.

30 Dec 2021

Influenza News and Research

Latest Influenza News and Research

New lab-on-a-chip platform for detecting SARS-CoV-2 in resource-limited settings

Influenza vaccination does not affect risk of SARS-CoV-2 infection or COVID-19

Comparison of COVID-19 and influenza-associated complications

Reinfection with SARS-CoV-2 in children

SARS-CoV-2 Omicron belongs to new antigenic cluster compared to all other VOCs

COVID-19 vaccines effective at varying intensities of SARS-CoV-2 exposure

New method to estimate how individual mutations affect transmission of SARS-CoV-2

Distrust in state power closely linked vaccine hesitancy

Impact of delaying the lifting of SARS-CoV-2 lockdown restrictions

Can the COVID-19 delta variant evade vaccine-induced immunity?

Novel insight into the immune characteristics of bats

Experts cautiously optimistic about risks of Delta-Omicron mutations mix

In vitro effect of several antiviral drugs against various SARS-CoV-2 variants of concern

The impact of natural selection on sequence diversity in SARS-CoV-2

Omicron spike-specific binding antibodies attenuate disease, despite increasing transmission

Echinacea, a potent antiviral against SARS-CoV-2

The use of monoclonal antibodies against infectious pathogens

Recombinant adjuvanted zoster vaccination associated with lower risk of COVID-19 diagnosis and hospitalization

Study explores relative reproduction of the SARS-CoV-2 omicron variant in South Africa

Omicron analysis shows no clear evidence for increased virulence or lethality

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Influenza News and Research

Latest Influenza News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in